Cover Image
Market Research Report

Bioengineered Skin Substitutes to 2018 - Therapeutics, Markets, Strategies and Forecasts

Published by Greystone Research Associates Product code 240075
Published Content info
Delivery time: 1-2 business days
Back to Top
Bioengineered Skin Substitutes to 2018 - Therapeutics, Markets, Strategies and Forecasts
Published: April 26, 2014 Content info:

Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world's leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin.


  • Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for replacing or augmenting damaged or diseased skin
  • Provides detailed analysis of bioengineered skin substitute products
  • Assesses business risk factors and market issues
  • Analyzes technology and product developments, and provides forecasts through 2018
  • Profiles bioengineered skin substitute companies, their product development activities, and strategies

What You Will Learn

  • What are the key segments and patient demographics that comprise the market for engineered skin substitutes?
  • What are the major therapeutic demand drivers for bioengineered skin substitutes?
  • What are the design factors, material selection issues and technologies that are being used in commercial and development-stage engineered skin substitute products?
  • What is the market share and product position in the market and what will it look like in 2018?
  • Who are the companies behind the current generation of bioengineered skin substitutes and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging bioengineered skin substitutes?
  • What is the impact of economic, technology, and regulatory factors?
Table of Contents
Product Code: ESK698F

Table of Contents

Executive Summary

Advanced Bioengineered Tissue Market Dynamics

  • Market Segmentation
    • Acute Wounds
    • Chronic Wounds & Ulcers
    • Surgical Wounds
    • Burns
  • Market and Patient Demographics
    • Market Dynamics
    • Factors Limiting Growth
  • Industry Profile
    • Industry Structure
    • Competitive Landscape
    • Technology Market Drivers

Bioengineered Skin Substitute Product Analysis

  • Acellular Matrices
  • Allogeneic Matrices
  • Allogeneic Sheets
  • Bilayered Skin Substitutes
  • Bioabsorbable Scaffolds
  • Extracellular Matrix
  • Collagen Biomembranes
  • Xenografts
  • Non-FDA Cleared Skin Substitutes
    • Extracellular Matrices
    • Cultured Epidermal Autografts

Market Sector Data, Assessments & Forecasts

  • Acute Trauma
  • Burns
  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers

Business Sector Strategies and Risks

  • Proprietary Technology
  • Near-term Capitalization
  • Strategic Alliances & Partnerships
  • Development Stage Transition Factors
  • Enabling Technologies

Market Factors

  • Clinical Trial Factors
  • FDA Guidelines
  • Reimbursement
  • Evolving Patient Demographics
  • Point-of-Care Processing
  • Protocols and End-Points

Company Profiles

Back to Top